Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Platelet Rich Plasma and Stem Cell Alopecia Treatment Market is presumed to reach the market size of nearly USD 728.1 Million by 2032 from USD 435.01 Million in 2023 with a CAGR of 5.89% under the study period 2024 - 2032.

Platelet rich plasma and stem cell alopecia treatment is a regenerative therapy aimed at stimulating hair growth and improving hair density in individuals experiencing hair loss or thinning. This treatment involves harvesting platelet-rich plasma (PRP) and stem cells from the patient's own blood or adipose tissue and injecting them into the scalp. PRP and stem cells contain growth factors and cytokines that promote tissue regeneration and hair follicle proliferation, potentially restoring hair growth in areas affected by alopecia.

MARKET DYNAMICS

The platelet-rich plasma (PRP) and stem cell alopecia treatment market is witnessing significant growth driven by several key factors. One primary driver is the increasing prevalence of hair loss disorders, including alopecia areata & androgenetic alopecia, fueled by an aging population, hormonal imbalances, and lifestyle factors. PRP and stem cell-based treatments offer promising solutions for hair restoration by stimulating hair follicle regeneration and promoting hair growth. Moreover, the growing demand for noninvasive and natural hair restoration therapies and the effectiveness and safety profile of PRP and stem cell treatments drive market adoption. Additionally, advancements in regenerative medicine techniques, including cell isolation, processing, and delivery methods, enhance treatment outcomes and expand market opportunities.

Furthermore, the rising consumer awareness of cosmetic procedures and the growing acceptance of regenerative medicine approaches in aesthetic treatments fuel market demand. Moreover, the increasing availability of PRP and stem cell alopecia treatments in specialized clinics and aesthetic centers is driving accessibility and affordability. Furthermore, strategic collaborations, partnerships, and investments among key aesthetic and regenerative medicine players foster research and development activities, thereby driving market innovation and growth. However, limited long-term efficacy data, regulatory constraints, and reimbursement limitations may hinder market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of platelet rich plasma and stem cell alopecia treatment. The growth and trends of platelet rich plasma and stem cell alopecia treatment industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the platelet rich plasma and stem cell alopecia treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Treatment

Platelet Rich Plasma Therapy
Stem Cell Therapy
Bone Marrow
Adipose

By Indication

Androgenic Alopecia
Congenital Alopecia
Cicatricial Or Scarring Alopecia
Others

By End-User

Hospitals
Dermatology Clinics
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Platelet Rich Plasma and Stem Cell Alopecia Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Platelet Rich Plasma and Stem Cell Alopecia Treatment market include Kerastem, Eclipse, Regen Lab SA, Restore Hair, RepliCel Life Sciences, Histogen Inc., Glofinn Oy. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR112114204

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . PLATELET RICH PLASMA AND STEM CELL ALOPECIA TREATMENT - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Treatment
- 3.7.2 Market Attractiveness Analysis By Indication
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL PLATELET RICH PLASMA AND STEM CELL ALOPECIA TREATMENT MARKET ANALYSIS BY TREATMENT

5.1 Overview by Treatment
5.2 Historical and Forecast Data
5.3 Analysis by Treatment
5.4 Platelet Rich Plasma Therapy Historic and Forecast Sales by Regions
5.5 Stem Cell Therapy Historic and Forecast Sales by Regions
5.6 Bone Marrow Historic and Forecast Sales by Regions
5.7 Adipose Historic and Forecast Sales by Regions

6 . GLOBAL PLATELET RICH PLASMA AND STEM CELL ALOPECIA TREATMENT MARKET ANALYSIS BY INDICATION

6.1 Overview by Indication
6.2 Historical and Forecast Data
6.3 Analysis by Indication
6.4 Androgenic Alopecia Historic and Forecast Sales by Regions
6.5 Congenital Alopecia Historic and Forecast Sales by Regions
6.6 Cicatricial or Scarring Alopecia Historic and Forecast Sales by Regions
6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL PLATELET RICH PLASMA AND STEM CELL ALOPECIA TREATMENT MARKET ANALYSIS BY END-USER

7.1 Overview by End-user
7.2 Historical and Forecast Data
7.3 Analysis by End-user
7.4 Hospitals Historic and Forecast Sales by Regions
7.5 Dermatology Clinics Historic and Forecast Sales by Regions
7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL PLATELET RICH PLASMA AND STEM CELL ALOPECIA TREATMENT MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE PLATELET RICH PLASMA AND STEM CELL ALOPECIA TREATMENT COMPANIES

9.1. Platelet Rich Plasma And Stem Cell Alopecia Treatment Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF PLATELET RICH PLASMA AND STEM CELL ALOPECIA TREATMENT INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Kerastem
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Eclipse
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Regen Lab SA
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Restore Hair
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. RepliCel Life Sciences
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Histogen Inc.
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Glofinn Oy
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies